Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

AbbVie Deutschland discloses 5-HT2C receptor agonists

Sep. 29, 2015

Takeda Pharmaceutical reports development of acyl-CoA desaturase inhibitors

Sep. 29, 2015

Columbia University in the City of New York patents MOR-1 agonists

Sep. 29, 2015

A*STAR develops HDAC inhibitors

Sep. 28, 2015

Chong Kun Dang Holdings discloses HDAC6 inhibitors

Sep. 28, 2015

RaQualia designs TRPM8 antagonists

Sep. 28, 2015

GlaxoSmithKline describes PERK inhibitors

Sep. 28, 2015

Lilly patents BACE1 inhibitors

Sep. 28, 2015

Helsinn Healthcare divulges ghrelin receptor antagonists

Sep. 25, 2015

University of California and McGill University present Mcl-1 inhibitors

Sep. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...